A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors | MicrobiomeTrials← Back to trialsNCT02671435
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2016-02-22Est. Completion: 2021-10-26
Enrollment target: 383 participants Locations- Research Site, Birmingham, Alabama, United States
- Research Site, Scottsdale, Arizona, United States
- Research Site, Duarte, California, United States
- Research Site, La Jolla, California, United States
- Research Site, Los Angeles, California, United States
- Research Site, Sacramento, California, United States
- Research Site, Santa Monica, California, United States
- Research Site, Aurora, Colorado, United States
- Research Site, Tampa, Florida, United States
- Research Site, Chicago, Illinois, United States
- Research Site, Baltimore, Maryland, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, Detroit, Michigan, United States
- Research Site, New Brunswick, New Jersey, United States
- Research Site, New Hyde Park, New York, United States
- Research Site, New York, New York, United States
- Research Site, The Bronx, New York, United States
- Research Site, Providence, Rhode Island, United States
Other microbiome trials you might be interested in
MelanomaAdvanced MelanomaMetastatic MelanomaUnresectable Melanoma
CMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monot…
Phoenix, United StatesCompleted Jul 22, 2024
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell CarcinomaCervical Adenocarcinoma
Research Site, Nashville, Tennessee, United StatesResearch Site, Dallas, Texas, United StatesResearch Site, San Antonio, Texas, United StatesResearch Site, Salt Lake City, Utah, United StatesResearch Site, Blacktown, AustraliaResearch Site, Clayton, AustraliaResearch Site, Waratah, AustraliaResearch Site, Brussels, BelgiumResearch Site, Edegem, BelgiumResearch Site, Leuven, BelgiumResearch Site, Vancouver, British Columbia, CanadaResearch Site, Toronto, Ontario, CanadaResearch Site, Marseille, FranceResearch Site, Nantes, FranceResearch Site, Debrecen, HungaryResearch Site, Milan, ItalyResearch Site, Milan, ItalyResearch Site, Grafton, New ZealandResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Barcelona, SpainResearch Site, Madrid, SpainResearch Site, Madrid, SpainResearch Site, Málaga, SpainResearch Site, Pamplona, SpainResearch Site, Seville, SpainResearch Site, London, United KingdomResearch Site, Sutton, United KingdomCervical Adenosquamous Carcinoma
Cervical Squamous Cell Carcinoma
Stage IB2 Cervical Cancer AJCC v6 and v7
Stage II Cervical Cancer AJCC v7
Stage II Vaginal Cancer AJCC v6 and v7
Stage IIA Cervical Cancer AJCC v7
Stage IIB Cervical Cancer AJCC v6 and v7
Stage III Vaginal Cancer AJCC v6 and v7
Stage IIIB Cervical Cancer AJCC v6 and v7
Stage IV Vaginal Cancer AJCC v6 and v7
Stage IVA Cervical Cancer AJCC v6 and v7
Stage IVA Vaginal Cancer AJCC v6 and v7
Unresectable Vaginal Carcinoma
Vaginal Adenocarcinoma
Vaginal Adenosquamous Carcinoma
Vaginal Carcinoma
Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
This randomized phase III trial studies radiation therapy and cisplatin with triapine to see how well they work compared…
Birmingham, United StatesEst. completion Jan 26, 2023
Locally Advanced Pancreatic CarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Unresectable Pancreatic Carcinoma
This phase I trial tests the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in…
Irvine, United StatesCompleted Jul 1, 2026